ARCHIVES

ORI Says COMS Study Coordinator Committed Scientific Misconduct

This article is from The Cancer Letter archive.

Vol. 22 No. 15 | April 12, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010

Organ Site Review Committee Recommends Continuing Program Despite Some Weak Areas, Suggests Changes

February 5, 1982

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI

May 19, 1989

Sen. Edward Kennedy Receives ACS Medal

January 23, 2009

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974